Skip to content

CCR5 antagonists unlikely to aggravate hepatitis C infection, French study reports

Hepatitis C virus coinfection does not lead to faster HIV disease progression in US women's study

Coinfection with hepatitis G has no benefit, finds study conducted amongst African women with HIV-1 and HIV-2

European consensus meeting draws up guidelines on HIV and hepatitis treatment

US approves Pegasys with ribavirin for chronic HCV in HIV/HCV coinfected adults; adds NRTI warning

Fibrosis progression may be faster than expected in HCV/HIV-coinfected patients

Tenofovir at least equivalent to adefovir for treatment of hepatitis B in HIV-infected patients

Entecavir gains ground as anti-HBV option in HIV-coinfected patients

Pegasys approved in Europe for treatment of HCV in HIV/HCV coinfected patients